Your browser doesn't support javascript.
loading
Survival Outcomes From a Cumulative Analysis of Worldwide Observational Studies on Sequential Use of New Agents in Metastatic Castration-Resistant Prostate Cancer.
Caffo, Orazio; Wissing, Michel; Bianchini, Diletta; Bergman, Andries; Thomsen, Frederik B; Schmid, Sebastian; Yu, Evan Y; Bournakis, Evangelos; Sella, Avishay; Zagonel, Vittorina; De Giorgi, Ugo; Tucci, Marcello; Gelderblom, Hans; Galli, Luca; Pappagallo, Giovanni; Bria, Emilio; Sperduti, Isabella; Oudard, Stephane.
Afiliação
  • Caffo O; Medical Oncology Department, Santa Chiara Hospital, Trento, Italy. Electronic address: orazio.caffo@apss.tn.it.
  • Wissing M; Medical Oncology Department, University Medical Centre, Leiden, the Netherlands.
  • Bianchini D; Division of Clinical Studies, Prostate Cancer Targeted Therapies Group, Royal Marsden NHS Foundation Trust, Sutton, United Kingdom.
  • Bergman A; Division of Internal Medicine (MOD) and Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Thomsen FB; Copenhagen Prostate Cancer Center, Rigshospitalet, Copenhagen, Denmark.
  • Schmid S; Klinik und Poliklinik für Urologie, Klinikum rechts der Isar der Technischen Universität München, München, Germany.
  • Yu EY; Department of Medicine, University of Washington School of Medicine, Seattle, WA.
  • Bournakis E; Oncology Department, ARETAIEIO University Hospital of Athens, IASO General Clinic of Athens, Athens, Greece.
  • Sella A; Department of Oncology, Yitzhak Shamir Medical Center, Assaf Harofe Campus Harofeh Medical Center, Sackler School of Medicine, Tel-Aviv, Israel.
  • Zagonel V; Medical Oncology Department, Istituto Oncologico Veneto, Padua, Italy.
  • De Giorgi U; Medical Oncology Department, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy.
  • Tucci M; Medical Oncology Department, Azienda Ospedaliera Universitaria S. Luigi Gonzaga, Orbassano, Italy.
  • Gelderblom H; Medical Oncology Department, University Medical Centre, Leiden, the Netherlands.
  • Galli L; Medical Oncology Department, Azienda Ospedaliera Universitaria, Pisa, Italy.
  • Pappagallo G; Epidemiology & Clinical Trials Office, General Hospital, Mirano, Italy.
  • Bria E; Oncology Unit, Università Cattolica del Sacro Cuore, Fondazione Policlinico "A. Gemelli", Rome, Italy.
  • Sperduti I; Biostatistical Unit, Regina Elena National Cancer Institute, Rome, Italy.
  • Oudard S; Service de cancérologie médicale, Hôpital Européen Georges Pompidou, René Descartes University, Paris, France.
Clin Genitourin Cancer ; 18(1): 69-76.e4, 2020 02.
Article em En | MEDLINE | ID: mdl-31767448
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Antagonistas de Receptores de Andrógenos / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Revista: Clin Genitourin Cancer Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Antagonistas de Receptores de Andrógenos / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Revista: Clin Genitourin Cancer Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2020 Tipo de documento: Article